MCM3_HUMAN - dbPTM
MCM3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MCM3_HUMAN
UniProt AC P25205
Protein Name DNA replication licensing factor MCM3
Gene Name MCM3
Organism Homo sapiens (Human).
Sequence Length 808
Subcellular Localization Nucleus.
Protein Description Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for DNA replication and cell proliferation..
Protein Sequence MAGTVVLDDVELREAQRDYLDFLDDEEDQGIYQSKVRELISDNQYRLIVNVNDLRRKNEKRANRLLNNAFEELVAFQRALKDFVASIDATYAKQYEEFYVGLEGSFGSKHVSPRTLTSCFLSCVVCVEGIVTKCSLVRPKVVRSVHYCPATKKTIERRYSDLTTLVAFPSSSVYPTKDEENNPLETEYGLSVYKDHQTITIQEMPEKAPAGQLPRSVDVILDDDLVDKAKPGDRVQVVGTYRCLPGKKGGYTSGTFRTVLIACNVKQMSKDAQPSFSAEDIAKIKKFSKTRSKDIFDQLAKSLAPSIHGHDYVKKAILCLLLGGVERDLENGSHIRGDINILLIGDPSVAKSQLLRYVLCTAPRAIPTTGRGSSGVGLTAAVTTDQETGERRLEAGAMVLADRGVVCIDEFDKMSDMDRTAIHEVMEQGRVTIAKAGIHARLNARCSVLAAANPVYGRYDQYKTPMENIGLQDSLLSRFDLLFIMLDQMDPEQDREISDHVLRMHRYRAPGEQDGDAMPLGSAVDILATDDPNFSQEDQQDTQIYEKHDNLLHGTKKKKEKMVSAAFMKKYIHVAKIIKPVLTQESATYIAEEYSRLRSQDSMSSDTARTSPVTARTLETLIRLATAHAKARMSKTVDLQDAEEAVELVQYAYFKKVLEKEKKRKKRSEDESETEDEEEKSQEDQEQKRKRRKTRQPDAKDGDSYDPYDFSDTEEEMPQVHTPKTADSQETKESQKVELSESRLKAFKVALLDVFREAHAQSIGMNRLTESINRDSEEPFSSVEIQAALSKMQDDNQVMVSEGIIFLI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAGTVVLDD
------CCCEEEECH
23.5122223895
4Phosphorylation----MAGTVVLDDVE
----CCCEEEECHHH
9.6323401153
19PhosphorylationLREAQRDYLDFLDDE
HHHHHHHHHHHCCCC
15.4522817900
32PhosphorylationDEEDQGIYQSKVREL
CCCCCCCCHHHHHHH
17.3522817900
34PhosphorylationEDQGIYQSKVRELIS
CCCCCCHHHHHHHHC
19.02-
35UbiquitinationDQGIYQSKVRELISD
CCCCCHHHHHHHHCC
29.7721906983
45PhosphorylationELISDNQYRLIVNVN
HHHCCCCEEEEEEHH
17.40-
55MethylationIVNVNDLRRKNEKRA
EEEHHHHHHHHHHHH
50.84115482835
64PhosphorylationKNEKRANRLLNNAFE
HHHHHHHHHHHHHHH
39.30-
77PhosphorylationFEELVAFQRALKDFV
HHHHHHHHHHHHHHH
21.72-
80UbiquitinationLVAFQRALKDFVASI
HHHHHHHHHHHHHHC
6.27-
80UbiquitinationLVAFQRALKDFVASI
HHHHHHHHHHHHHHC
6.27-
812-HydroxyisobutyrylationVAFQRALKDFVASID
HHHHHHHHHHHHHCC
48.40-
81AcetylationVAFQRALKDFVASID
HHHHHHHHHHHHHCC
48.4026051181
81UbiquitinationVAFQRALKDFVASID
HHHHHHHHHHHHHCC
48.40-
86PhosphorylationALKDFVASIDATYAK
HHHHHHHHCCHHHHH
18.7228152594
90PhosphorylationFVASIDATYAKQYEE
HHHHCCHHHHHHCCE
21.9228152594
91PhosphorylationVASIDATYAKQYEEF
HHHCCHHHHHHCCEE
17.3328152594
100MethylationKQYEEFYVGLEGSFG
HHCCEEEECCCCCCC
9.53-
112PhosphorylationSFGSKHVSPRTLTSC
CCCCCCCCHHHHHHH
14.3721658608
126UbiquitinationCFLSCVVCVEGIVTK
HHHHHHHHHHCHHHH
0.85-
126UbiquitinationCFLSCVVCVEGIVTK
HHHHHHHHHHCHHHH
0.85-
135PhosphorylationEGIVTKCSLVRPKVV
HCHHHHCCCCCCCCE
31.3024719451
140UbiquitinationKCSLVRPKVVRSVHY
HCCCCCCCCEEEEEE
42.68-
144PhosphorylationVRPKVVRSVHYCPAT
CCCCCEEEEEECCCC
11.1323401153
147NitrationKVVRSVHYCPATKKT
CCEEEEEECCCCHHH
9.66-
147PhosphorylationKVVRSVHYCPATKKT
CCEEEEEECCCCHHH
9.6628152594
148S-nitrosocysteineVVRSVHYCPATKKTI
CEEEEEECCCCHHHH
0.82-
148S-nitrosylationVVRSVHYCPATKKTI
CEEEEEECCCCHHHH
0.8219483679
151PhosphorylationSVHYCPATKKTIERR
EEEECCCCHHHHHHH
20.4427080861
1522-HydroxyisobutyrylationVHYCPATKKTIERRY
EEECCCCHHHHHHHH
50.45-
152AcetylationVHYCPATKKTIERRY
EEECCCCHHHHHHHH
50.4525953088
152UbiquitinationVHYCPATKKTIERRY
EEECCCCHHHHHHHH
50.45-
154O-linked_GlycosylationYCPATKKTIERRYSD
ECCCCHHHHHHHHCC
29.6228510447
154PhosphorylationYCPATKKTIERRYSD
ECCCCHHHHHHHHCC
29.6221406692
157PhosphorylationATKKTIERRYSDLTT
CCHHHHHHHHCCCCE
38.70-
159PhosphorylationKKTIERRYSDLTTLV
HHHHHHHHCCCCEEE
16.8621712546
160PhosphorylationKTIERRYSDLTTLVA
HHHHHHHCCCCEEEE
25.0825159151
163PhosphorylationERRYSDLTTLVAFPS
HHHHCCCCEEEECCC
24.0725159151
164PhosphorylationRRYSDLTTLVAFPSS
HHHCCCCEEEECCCC
26.9122617229
170PhosphorylationTTLVAFPSSSVYPTK
CEEEECCCCCCCCCC
28.8820873877
171PhosphorylationTLVAFPSSSVYPTKD
EEEECCCCCCCCCCC
24.8620873877
172PhosphorylationLVAFPSSSVYPTKDE
EEECCCCCCCCCCCC
29.9720873877
174PhosphorylationAFPSSSVYPTKDEEN
ECCCCCCCCCCCCCC
13.7220873877
176PhosphorylationPSSSVYPTKDEENNP
CCCCCCCCCCCCCCC
33.1820873877
177UbiquitinationSSSVYPTKDEENNPL
CCCCCCCCCCCCCCC
59.65-
185UbiquitinationDEENNPLETEYGLSV
CCCCCCCEEECEEEE
40.63-
185UbiquitinationDEENNPLETEYGLSV
CCCCCCCEEECEEEE
40.63-
186PhosphorylationEENNPLETEYGLSVY
CCCCCCEEECEEEEE
42.0427080861
188PhosphorylationNNPLETEYGLSVYKD
CCCCEEECEEEEEEC
30.6827080861
189PhosphorylationNPLETEYGLSVYKDH
CCCEEECEEEEEECC
12.7827251275
191PhosphorylationLETEYGLSVYKDHQT
CEEECEEEEEECCCE
21.0227080861
193PhosphorylationTEYGLSVYKDHQTIT
EECEEEEEECCCEEE
13.8127080861
197UbiquitinationLSVYKDHQTITIQEM
EEEEECCCEEEEEEC
44.74-
198PhosphorylationSVYKDHQTITIQEMP
EEEECCCEEEEEECC
19.37-
199PhosphorylationVYKDHQTITIQEMPE
EEECCCEEEEEECCC
2.28-
204PhosphorylationQTITIQEMPEKAPAG
CEEEEEECCCCCCCC
2.73-
205PhosphorylationTITIQEMPEKAPAGQ
EEEEEECCCCCCCCC
38.9019651622
207AcetylationTIQEMPEKAPAGQLP
EEEECCCCCCCCCCC
54.5226051181
207UbiquitinationTIQEMPEKAPAGQLP
EEEECCCCCCCCCCC
54.5221906983
208PhosphorylationIQEMPEKAPAGQLPR
EEECCCCCCCCCCCC
9.49-
209PhosphorylationQEMPEKAPAGQLPRS
EECCCCCCCCCCCCC
48.2520068231
216PhosphorylationPAGQLPRSVDVILDD
CCCCCCCCEEEEECH
22.2621601212
222SumoylationRSVDVILDDDLVDKA
CCEEEEECHHHHCCC
35.93-
222UbiquitinationRSVDVILDDDLVDKA
CCEEEEECHHHHCCC
35.93-
228UbiquitinationLDDDLVDKAKPGDRV
ECHHHHCCCCCCCEE
51.32-
230UbiquitinationDDLVDKAKPGDRVQV
HHHHCCCCCCCEEEE
56.10-
234MethylationDKAKPGDRVQVVGTY
CCCCCCCEEEEEEEE
27.0416188073
240PhosphorylationDRVQVVGTYRCLPGK
CEEEEEEEEECCCCC
9.00-
243PhosphorylationQVVGTYRCLPGKKGG
EEEEEEECCCCCCCC
3.66-
248SumoylationYRCLPGKKGGYTSGT
EECCCCCCCCCCCCC
64.58-
248AcetylationYRCLPGKKGGYTSGT
EECCCCCCCCCCCCC
64.5826051181
248UbiquitinationYRCLPGKKGGYTSGT
EECCCCCCCCCCCCC
64.58-
252UbiquitinationPGKKGGYTSGTFRTV
CCCCCCCCCCCHHEE
24.77-
252PhosphorylationPGKKGGYTSGTFRTV
CCCCCCCCCCCHHEE
24.7730108239
252UbiquitinationPGKKGGYTSGTFRTV
CCCCCCCCCCCHHEE
24.77-
253PhosphorylationGKKGGYTSGTFRTVL
CCCCCCCCCCHHEEE
27.6128450419
255PhosphorylationKGGYTSGTFRTVLIA
CCCCCCCCHHEEEEE
15.0928450419
258PhosphorylationYTSGTFRTVLIACNV
CCCCCHHEEEEEECH
18.57-
266SumoylationVLIACNVKQMSKDAQ
EEEEECHHHCCCCCC
26.71-
266AcetylationVLIACNVKQMSKDAQ
EEEEECHHHCCCCCC
26.7125953088
266UbiquitinationVLIACNVKQMSKDAQ
EEEEECHHHCCCCCC
26.7121890473
269PhosphorylationACNVKQMSKDAQPSF
EECHHHCCCCCCCCC
25.5322817901
270UbiquitinationCNVKQMSKDAQPSFS
ECHHHCCCCCCCCCC
52.30-
273UbiquitinationKQMSKDAQPSFSAED
HHCCCCCCCCCCHHH
44.28-
273UbiquitinationKQMSKDAQPSFSAED
HHCCCCCCCCCCHHH
44.28-
275UbiquitinationMSKDAQPSFSAEDIA
CCCCCCCCCCHHHHH
21.54-
275PhosphorylationMSKDAQPSFSAEDIA
CCCCCCCCCCHHHHH
21.5425159151
275UbiquitinationMSKDAQPSFSAEDIA
CCCCCCCCCCHHHHH
21.54-
277PhosphorylationKDAQPSFSAEDIAKI
CCCCCCCCHHHHHHH
34.7830576142
279MethylationAQPSFSAEDIAKIKK
CCCCCCHHHHHHHHH
49.07-
283AcetylationFSAEDIAKIKKFSKT
CCHHHHHHHHHHCCC
56.2326822725
283UbiquitinationFSAEDIAKIKKFSKT
CCHHHHHHHHHHCCC
56.23-
285AcetylationAEDIAKIKKFSKTRS
HHHHHHHHHHCCCCC
47.2425953088
290PhosphorylationKIKKFSKTRSKDIFD
HHHHHCCCCCHHHHH
38.6923312004
292PhosphorylationKKFSKTRSKDIFDQL
HHHCCCCCHHHHHHH
39.6520873877
293UbiquitinationKFSKTRSKDIFDQLA
HHCCCCCHHHHHHHH
52.10-
293AcetylationKFSKTRSKDIFDQLA
HHCCCCCHHHHHHHH
52.10-
293SumoylationKFSKTRSKDIFDQLA
HHCCCCCHHHHHHHH
52.10-
293UbiquitinationKFSKTRSKDIFDQLA
HHCCCCCHHHHHHHH
52.1021890473
301UbiquitinationDIFDQLAKSLAPSIH
HHHHHHHHHHCHHHC
55.3721890473
303PhosphorylationFDQLAKSLAPSIHGH
HHHHHHHHCHHHCCH
8.83-
311UbiquitinationAPSIHGHDYVKKAIL
CHHHCCHHHHHHHHH
55.2921890473
311SumoylationAPSIHGHDYVKKAIL
CHHHCCHHHHHHHHH
55.29-
311UbiquitinationAPSIHGHDYVKKAIL
CHHHCCHHHHHHHHH
55.29-
312PhosphorylationPSIHGHDYVKKAILC
HHHCCHHHHHHHHHH
14.43-
314AcetylationIHGHDYVKKAILCLL
HCCHHHHHHHHHHHH
30.2026051181
315UbiquitinationHGHDYVKKAILCLLL
CCHHHHHHHHHHHHH
30.52-
315UbiquitinationHGHDYVKKAILCLLL
CCHHHHHHHHHHHHH
30.52-
320PhosphorylationVKKAILCLLLGGVER
HHHHHHHHHHCCCHH
3.87-
328UbiquitinationLLGGVERDLENGSHI
HHCCCHHHCCCCCCC
44.84-
333PhosphorylationERDLENGSHIRGDIN
HHHCCCCCCCCCCEE
27.5920068231
337PhosphorylationENGSHIRGDINILLI
CCCCCCCCCEEEEEE
39.28-
338UbiquitinationNGSHIRGDINILLIG
CCCCCCCCEEEEEEC
22.4021890473
338UbiquitinationNGSHIRGDINILLIG
CCCCCCCCEEEEEEC
22.40-
346UbiquitinationINILLIGDPSVAKSQ
EEEEEECCHHHHHHH
25.8821890473
346UbiquitinationINILLIGDPSVAKSQ
EEEEEECCHHHHHHH
25.88-
3512-HydroxyisobutyrylationIGDPSVAKSQLLRYV
ECCHHHHHHHHHHHH
36.26-
351UbiquitinationIGDPSVAKSQLLRYV
ECCHHHHHHHHHHHH
36.2621890473
357PhosphorylationAKSQLLRYVLCTAPR
HHHHHHHHHHHCCCC
9.57-
359UbiquitinationSQLLRYVLCTAPRAI
HHHHHHHHHCCCCCC
1.27-
360UbiquitinationQLLRYVLCTAPRAIP
HHHHHHHHCCCCCCC
1.86-
360GlutathionylationQLLRYVLCTAPRAIP
HHHHHHHHCCCCCCC
1.8622555962
360S-palmitoylationQLLRYVLCTAPRAIP
HHHHHHHHCCCCCCC
1.8629575903
360UbiquitinationQLLRYVLCTAPRAIP
HHHHHHHHCCCCCCC
1.86-
369PhosphorylationAPRAIPTTGRGSSGV
CCCCCCCCCCCCCCC
21.3721210654
371MethylationRAIPTTGRGSSGVGL
CCCCCCCCCCCCCCC
39.46115482827
373PhosphorylationIPTTGRGSSGVGLTA
CCCCCCCCCCCCCEE
23.6626033855
374PhosphorylationPTTGRGSSGVGLTAA
CCCCCCCCCCCCEEE
40.0826033855
379PhosphorylationGSSGVGLTAAVTTDQ
CCCCCCCEEEEECCC
13.4726033855
383PhosphorylationVGLTAAVTTDQETGE
CCCEEEEECCCCCCC
21.67-
384PhosphorylationGLTAAVTTDQETGER
CCEEEEECCCCCCCH
29.14-
396UbiquitinationGERRLEAGAMVLADR
CCHHHHHHCEEEECC
12.5821890473
396UbiquitinationGERRLEAGAMVLADR
CCHHHHHHCEEEECC
12.58-
413AcetylationVCIDEFDKMSDMDRT
EEECCCCCCCCCCHH
45.7026822725
413UbiquitinationVCIDEFDKMSDMDRT
EEECCCCCCCCCCHH
45.70-
416MethylationDEFDKMSDMDRTAIH
CCCCCCCCCCHHHHH
39.23-
419MethylationDKMSDMDRTAIHEVM
CCCCCCCHHHHHHHH
21.30115482843
428PhosphorylationAIHEVMEQGRVTIAK
HHHHHHHCCCEEEEE
27.22-
429PhosphorylationIHEVMEQGRVTIAKA
HHHHHHCCCEEEEEC
16.84-
4352-HydroxyisobutyrylationQGRVTIAKAGIHARL
CCCEEEEECCHHHHH
43.21-
435AcetylationQGRVTIAKAGIHARL
CCCEEEEECCHHHHH
43.2125953088
435UbiquitinationQGRVTIAKAGIHARL
CCCEEEEECCHHHHH
43.2121890473
446GlutathionylationHARLNARCSVLAAAN
HHHHHHHHHHHHHHC
2.8322555962
456NitrationLAAANPVYGRYDQYK
HHHHCCCCCCCCCCC
9.35-
456PhosphorylationLAAANPVYGRYDQYK
HHHHCCCCCCCCCCC
9.3528152594
458UbiquitinationAANPVYGRYDQYKTP
HHCCCCCCCCCCCCC
17.73-
458UbiquitinationAANPVYGRYDQYKTP
HHCCCCCCCCCCCCC
17.73-
459PhosphorylationANPVYGRYDQYKTPM
HCCCCCCCCCCCCCH
11.7527174698
462PhosphorylationVYGRYDQYKTPMENI
CCCCCCCCCCCHHHC
17.5827174698
463UbiquitinationYGRYDQYKTPMENIG
CCCCCCCCCCHHHCC
40.2821906983
464MethylationGRYDQYKTPMENIGL
CCCCCCCCCHHHCCC
23.96-
464PhosphorylationGRYDQYKTPMENIGL
CCCCCCCCCHHHCCC
23.9627174698
466SulfoxidationYDQYKTPMENIGLQD
CCCCCCCHHHCCCCH
8.1321406390
474PhosphorylationENIGLQDSLLSRFDL
HHCCCCHHHHHHHHH
20.4627174698
477PhosphorylationGLQDSLLSRFDLLFI
CCCHHHHHHHHHHHH
35.8727174698
480UbiquitinationDSLLSRFDLLFIMLD
HHHHHHHHHHHHHHH
41.1521890473
480UbiquitinationDSLLSRFDLLFIMLD
HHHHHHHHHHHHHHH
41.15-
508UbiquitinationVLRMHRYRAPGEQDG
HHHHHCCCCCCCCCC
33.97-
508UbiquitinationVLRMHRYRAPGEQDG
HHHHHCCCCCCCCCC
33.97-
519PhosphorylationEQDGDAMPLGSAVDI
CCCCCCCCCCHHHHE
34.98-
522PhosphorylationGDAMPLGSAVDILAT
CCCCCCCHHHHEEEC
32.5720873877
529PhosphorylationSAVDILATDDPNFSQ
HHHHEEECCCCCCCH
37.1728464451
535PhosphorylationATDDPNFSQEDQQDT
ECCCCCCCHHHHHCC
39.0230576142
542PhosphorylationSQEDQQDTQIYEKHD
CHHHHHCCHHHHHHH
16.7220873877
545PhosphorylationDQQDTQIYEKHDNLL
HHHCCHHHHHHHCCC
14.7628464451
547AcetylationQDTQIYEKHDNLLHG
HCCHHHHHHHCCCCC
39.01-
555PhosphorylationHDNLLHGTKKKKEKM
HHCCCCCCHHHHHHH
29.0128555341
5562-HydroxyisobutyrylationDNLLHGTKKKKEKMV
HCCCCCCHHHHHHHH
68.16-
556AcetylationDNLLHGTKKKKEKMV
HCCCCCCHHHHHHHH
68.1625953088
559AcetylationLHGTKKKKEKMVSAA
CCCCHHHHHHHHHHH
72.027975523
561AcetylationGTKKKKEKMVSAAFM
CCHHHHHHHHHHHHH
54.1825953088
564PhosphorylationKKKEKMVSAAFMKKY
HHHHHHHHHHHHHHH
15.4723403867
569AcetylationMVSAAFMKKYIHVAK
HHHHHHHHHHHHHHH
35.6525953088
570UbiquitinationVSAAFMKKYIHVAKI
HHHHHHHHHHHHHHH
37.33-
574PhosphorylationFMKKYIHVAKIIKPV
HHHHHHHHHHHHHHH
4.1527251275
579AcetylationIHVAKIIKPVLTQES
HHHHHHHHHHCCHHH
32.3326051181
579UbiquitinationIHVAKIIKPVLTQES
HHHHHHHHHHCCHHH
32.3321890473
580PhosphorylationHVAKIIKPVLTQESA
HHHHHHHHHCCHHHH
18.8815210935
599PhosphorylationEEYSRLRSQDSMSSD
HHHHHHHCCCCCCCC
42.82-
601UbiquitinationYSRLRSQDSMSSDTA
HHHHHCCCCCCCCCC
47.78-
602PhosphorylationSRLRSQDSMSSDTAR
HHHHCCCCCCCCCCC
16.9625954137
604PhosphorylationLRSQDSMSSDTARTS
HHCCCCCCCCCCCCC
29.0725954137
605PhosphorylationRSQDSMSSDTARTSP
HCCCCCCCCCCCCCC
30.2725954137
606UbiquitinationSQDSMSSDTARTSPV
CCCCCCCCCCCCCCC
36.76-
607PhosphorylationQDSMSSDTARTSPVT
CCCCCCCCCCCCCCH
21.7125954137
610PhosphorylationMSSDTARTSPVTART
CCCCCCCCCCCHHHH
34.6129214152
611PhosphorylationSSDTARTSPVTARTL
CCCCCCCCCCHHHHH
16.3023917254
614AcetylationTARTSPVTARTLETL
CCCCCCCHHHHHHHH
17.5119608861
615UbiquitinationARTSPVTARTLETLI
CCCCCCHHHHHHHHH
11.60-
615UbiquitinationARTSPVTARTLETLI
CCCCCCHHHHHHHHH
11.60-
617O-linked_GlycosylationTSPVTARTLETLIRL
CCCCHHHHHHHHHHH
26.8728510447
617PhosphorylationTSPVTARTLETLIRL
CCCCHHHHHHHHHHH
26.8720068231
620PhosphorylationVTARTLETLIRLATA
CHHHHHHHHHHHHHH
30.5120068231
624UbiquitinationTLETLIRLATAHAKA
HHHHHHHHHHHHHHH
3.8321890473
624UbiquitinationTLETLIRLATAHAKA
HHHHHHHHHHHHHHH
3.83-
6302-HydroxyisobutyrylationRLATAHAKARMSKTV
HHHHHHHHHHHCCCC
27.02-
651PhosphorylationEAVELVQYAYFKKVL
HHHHHHHHHHHHHHH
8.86-
656PhosphorylationVQYAYFKKVLEKEKK
HHHHHHHHHHHHHHH
42.00-
662PhosphorylationKKVLEKEKKRKKRSE
HHHHHHHHHHHHCCC
69.7920068231
668PhosphorylationEKKRKKRSEDESETE
HHHHHHCCCCCCCCH
59.2729255136
672PhosphorylationKKRSEDESETEDEEE
HHCCCCCCCCHHHHH
63.2429255136
674PhosphorylationRSEDESETEDEEEKS
CCCCCCCCHHHHHHH
59.0029255136
680UbiquitinationETEDEEEKSQEDQEQ
CCHHHHHHHHHHHHH
61.80-
681PhosphorylationTEDEEEKSQEDQEQK
CHHHHHHHHHHHHHH
41.9217525332
694PhosphorylationQKRKRRKTRQPDAKD
HHHHHHHHCCCCCCC
32.5023403867
700UbiquitinationKTRQPDAKDGDSYDP
HHCCCCCCCCCCCCC
70.40-
704PhosphorylationPDAKDGDSYDPYDFS
CCCCCCCCCCCCCCC
36.6423927012
705PhosphorylationDAKDGDSYDPYDFSD
CCCCCCCCCCCCCCC
26.1923927012
708PhosphorylationDGDSYDPYDFSDTEE
CCCCCCCCCCCCCCC
27.0723927012
711PhosphorylationSYDPYDFSDTEEEMP
CCCCCCCCCCCCCCC
40.5019664994
713PhosphorylationDPYDFSDTEEEMPQV
CCCCCCCCCCCCCCC
44.0623927012
717PhosphorylationFSDTEEEMPQVHTPK
CCCCCCCCCCCCCCC
2.9617525332
719PhosphorylationDTEEEMPQVHTPKTA
CCCCCCCCCCCCCCC
38.0117525332
722PhosphorylationEEMPQVHTPKTADSQ
CCCCCCCCCCCCCCH
27.8519664994
725PhosphorylationPQVHTPKTADSQETK
CCCCCCCCCCCHHCH
36.5828176443
726PhosphorylationQVHTPKTADSQETKE
CCCCCCCCCCHHCHH
22.1517525332
728PhosphorylationHTPKTADSQETKESQ
CCCCCCCCHHCHHHH
27.7023401153
731PhosphorylationKTADSQETKESQKVE
CCCCCHHCHHHHCEE
32.2628450419
732SumoylationTADSQETKESQKVEL
CCCCHHCHHHHCEEC
55.40-
732AcetylationTADSQETKESQKVEL
CCCCHHCHHHHCEEC
55.4026051181
732UbiquitinationTADSQETKESQKVEL
CCCCHHCHHHHCEEC
55.4021906983
733UbiquitinationADSQETKESQKVELS
CCCHHCHHHHCEECC
66.86-
734PhosphorylationDSQETKESQKVELSE
CCHHCHHHHCEECCH
36.5417525332
736SumoylationQETKESQKVELSESR
HHCHHHHCEECCHHH
47.13-
736AcetylationQETKESQKVELSESR
HHCHHHHCEECCHHH
47.1323236377
736UbiquitinationQETKESQKVELSESR
HHCHHHHCEECCHHH
47.13-
740PhosphorylationESQKVELSESRLKAF
HHHCEECCHHHHHHH
21.7421815630
742PhosphorylationQKVELSESRLKAFKV
HCEECCHHHHHHHHH
39.2727050516
743MethylationKVELSESRLKAFKVA
CEECCHHHHHHHHHH
35.84115482851
748UbiquitinationESRLKAFKVALLDVF
HHHHHHHHHHHHHHH
31.3021890473
749PhosphorylationSRLKAFKVALLDVFR
HHHHHHHHHHHHHHH
3.5220068231
750PhosphorylationRLKAFKVALLDVFRE
HHHHHHHHHHHHHHH
11.7317081983
753PhosphorylationAFKVALLDVFREAHA
HHHHHHHHHHHHHHH
38.0620068231
756PhosphorylationVALLDVFREAHAQSI
HHHHHHHHHHHHHHH
39.7919664994
758PhosphorylationLLDVFREAHAQSIGM
HHHHHHHHHHHHHCH
10.0820230923
762PhosphorylationFREAHAQSIGMNRLT
HHHHHHHHHCHHHHH
23.1522817901
767PhosphorylationAQSIGMNRLTESINR
HHHHCHHHHHHHHCC
33.8119664994
769PhosphorylationSIGMNRLTESINRDS
HHCHHHHHHHHCCCC
25.1722817901
770PhosphorylationIGMNRLTESINRDSE
HCHHHHHHHHCCCCC
54.97-
773PhosphorylationNRLTESINRDSEEPF
HHHHHHHCCCCCCCC
51.4917525332
776PhosphorylationTESINRDSEEPFSSV
HHHHCCCCCCCCCHH
40.3921406692
777UbiquitinationESINRDSEEPFSSVE
HHHCCCCCCCCCHHH
74.17-
777SumoylationESINRDSEEPFSSVE
HHHCCCCCCCCCHHH
74.17-
777UbiquitinationESINRDSEEPFSSVE
HHHCCCCCCCCCHHH
74.17-
779PhosphorylationINRDSEEPFSSVEIQ
HCCCCCCCCCHHHHH
30.3017525332
781AcetylationRDSEEPFSSVEIQAA
CCCCCCCCHHHHHHH
44.16-
781UbiquitinationRDSEEPFSSVEIQAA
CCCCCCCCHHHHHHH
44.16-
781PhosphorylationRDSEEPFSSVEIQAA
CCCCCCCCHHHHHHH
44.1621406692
781SumoylationRDSEEPFSSVEIQAA
CCCCCCCCHHHHHHH
44.16-
781UbiquitinationRDSEEPFSSVEIQAA
CCCCCCCCHHHHHHH
44.16-
782PhosphorylationDSEEPFSSVEIQAAL
CCCCCCCHHHHHHHH
24.9321406692
785PhosphorylationEPFSSVEIQAALSKM
CCCCHHHHHHHHHHC
2.94-
787PhosphorylationFSSVEIQAALSKMQD
CCHHHHHHHHHHCCC
18.94-
788MethylationSSVEIQAALSKMQDD
CHHHHHHHHHHCCCC
8.94-
790PhosphorylationVEIQAALSKMQDDNQ
HHHHHHHHHCCCCCC
22.7321406692
793UbiquitinationQAALSKMQDDNQVMV
HHHHHHCCCCCCEEE
59.6521890473
793UbiquitinationQAALSKMQDDNQVMV
HHHHHHCCCCCCEEE
59.65-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
160SPhosphorylationKinaseCHEK1O14757
GPS
160SPhosphorylationKinaseDAPK1P53355
PSP
160SPhosphorylationKinaseDAPK-FAMILY-GPS
535SPhosphorylationKinaseATMQ13315
Uniprot
535SPhosphorylationKinaseATRQ13535
PSP
722TPhosphorylationKinaseCDK2P24941
PSP
728SPhosphorylationKinaseATMQ62388
PSP
728SPhosphorylationKinaseATRQ9JKK8
PSP
-KUbiquitinationE3 ubiquitin ligaseKEAP1Q14145
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MCM3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MCM3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MCM2_HUMANMCM2physical
12614612
MCM5_HUMANMCM5physical
12614612
CDC45_HUMANCDC45physical
12614612
DBF4A_HUMANDBF4physical
12614612
ORC5_HUMANORC5physical
12614612
ORC4_HUMANORC4physical
12614612
MCM7_HUMANMCM7physical
12614612
GANP_HUMANMCM3APphysical
10733502
GANP_HUMANMCM3APphysical
9712829
MCM7_HUMANMCM7physical
11779870
LZTR1_HUMANLZTR1physical
20211142
SYF2_HUMANSYF2physical
16951160
CCL2_HUMANCCL2physical
21383955
HIF1A_HUMANHIF1Aphysical
21658608
EPAS1_HUMANEPAS1physical
21658608
CDK2_HUMANCDK2physical
21965652
CCNE1_HUMANCCNE1physical
21965652
MCM5_HUMANMCM5physical
22939629
MCM7_HUMANMCM7physical
22939629
MCM6_HUMANMCM6physical
22939629
MCM4_HUMANMCM4physical
22939629
RFA2_HUMANRPA2physical
22939629
RFC4_HUMANRFC4physical
22939629
RFC3_HUMANRFC3physical
22939629
PUR1_HUMANPPATphysical
22939629
MCM2_HUMANMCM2physical
15232106
MCM5_HUMANMCM5physical
15232106
MCM10_HUMANMCM10physical
15232106
ORC4_HUMANORC4physical
15232106
FKBP4_HUMANFKBP4physical
22863883
FKBP5_HUMANFKBP5physical
22863883
HS90A_HUMANHSP90AA1physical
22863883
SAE1_HUMANSAE1physical
22863883
TPM3_HUMANTPM3physical
22863883
SLD5_HUMANGINS4physical
26344197
HNRPF_HUMANHNRNPFphysical
26344197
HNRH2_HUMANHNRNPH2physical
26344197
HNRH3_HUMANHNRNPH3physical
26344197
MCFD2_HUMANMCFD2physical
26344197
MCM2_HUMANMCM2physical
26344197
MCM7_HUMANMCM7physical
26344197
MCMBP_HUMANMCMBPphysical
26344197
CNDD3_HUMANNCAPD3physical
26344197
NUP62_HUMANNUP62physical
26344197
NUP88_HUMANNUP88physical
26344197
RPB4_HUMANPOLR2Dphysical
26344197
ZO2_HUMANTJP2physical
26344197
1433G_HUMANYWHAGphysical
26344197
MCMBP_HUMANMCMBPphysical
28514442
MCM5_HUMANMCM5physical
28514442
TSNAX_HUMANTSNAXphysical
28514442
MCM7_HUMANMCM7physical
28514442
TIM_HUMANTIMELESSphysical
28514442
MCM4_HUMANMCM4physical
28514442
YIPF3_HUMANYIPF3physical
28514442
MCM2_HUMANMCM2physical
28514442
MCM6_HUMANMCM6physical
28514442
EAF1_HUMANEAF1physical
27173435
FACD2_HUMANFANCD2physical
23993743
MCM2_HUMANMCM2physical
23993743
MCM5_HUMANMCM5physical
23993743
MCM7_HUMANMCM7physical
23993743

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MCM3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-704; TYR-708; SER-711; THR-713 AND THR-722, ANDMASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672; THR-674; TYR-708;SER-711; THR-713; THR-722 AND THR-725, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-711 AND THR-722, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-704; TYR-708; SER-711; THR-713 AND THR-722, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-160; SER-668; SER-672;THR-674; SER-681; SER-711; THR-713 AND THR-722, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-711 AND THR-722, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672; THR-674; SER-681;SER-728 AND SER-734, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704; SER-711 ANDTHR-713, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672 AND THR-674, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672; THR-674; SER-711;THR-713 AND THR-722, AND MASS SPECTROMETRY.
"Minichromosome maintenance proteins are direct targets of the ATM andATR checkpoint kinases.";
Cortez D., Glick G., Elledge S.J.;
Proc. Natl. Acad. Sci. U.S.A. 101:10078-10083(2004).
Cited for: PHOSPHORYLATION AT SER-535, AND MUTAGENESIS OF SER-535.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-713 AND THR-722, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-713 AND THR-722, ANDMASS SPECTROMETRY.

TOP